Mosquito-borne viruses and male infertility: Zika was just the beginning – the impact of dengue on sperm DNA integrity Authors: Hafsa Tariq, Dua Asim, Mahnoor Sheikh, Jaber Hamad Jaber Amin Published: 2026 ABSTRACT Dengue is resurging globally (~14 million cases in 2024). Emerging evidence suggests that dengue infection may transiently impair male fertility. Acute dengue has been associated with reversible declines in sperm count, with potential increases in sperm DNA fragmentation, possibly mediated by fever-induced oxidative stress. We review dengue’s effects on sperm, compare them with Zika’s impact, and highlight implications for fertility counseling. To the Editor, Zika virus (ZIKV), an arthropod-borne flavivirus transmitted primarily by Aedes mosquitoes, has reshaped our understanding of viral impacts on male reproductive health. Unlike most arboviruses, ZIKV demonstrates sexual transmissibility and persistence within the male reproductive tract, with viral RNA detected in the semen of both symptomatic and asymptomatic individuals and localized to spermatozoa, particularly the mid-piece[1,2]. These observations have raised concerns about the male genital tract as a potential viral reservoir. Dengue virus (DENV), a closely related flavivirus, shares structural and molecular similarities with ZIKV, including envelope protein architecture and pathogenic mechanisms[3]. As a positive-sense RNA virus with four antigenically distinct serotypes (DENV-1 to DENV-4), dengue represents a significantly larger global burden, with recurrent epidemics and increasing incidence worldwide[4]. While DENV-2 has been most frequently associated with severe disease and outbreaks[5], its reproductive implications remain underexplored. Emerging evidence suggests that dengue infection may transiently impair male fertility; however, current clinical data remain limited. In a prospective cohort study, DENV RNA was detected in semen samples of infected individuals up to 30 days following symptom onset, although viral replication appeared minimal, indicating low infectivity[6]. While these findings suggest the possibility of short-term seminal shedding and reproductive involvement, they are derived from a single study and should be interpreted with caution. The underlying mechanisms appear to be largely indirect, mediated by systemic inflammation and oxidative stress. Viral infections, including dengue, trigger immune activation and cytokine release, leading to increased reactive oxygen species production. This oxidative environment disrupts spermatogenesis, damages sperm membranes, and induces DNA fragmentation[7]. Additionally, macrophage-mediated inflammation within testicular tissue promotes leukocyte infiltration, fibrosis, and germ cell apoptosis. Structural damage to Sertoli and Leydig cells further compromises spermatogenesis and testosterone production, exacerbating reproductive dysfunction[7,8]. Clinically, dengue infection has been associated with reduced sperm count and impaired motility, as reported in limited clinical data[6], while evidence regarding sperm DNA fragmentation remains largely inferential. Febrile hyperthermia during acute infection may further contribute to these changes by directly impairing seminiferous tubule function. Studies have demonstrated significant declines in sperm parameters during acute illness, with gradual recovery over subsequent months, supporting a reversible pathophysiological process[6]. However, the extent of sperm DNA damage and its implications for fertility outcomes remain insufficiently characterized. Importantly, the intersection of dengue epidemiology and reproductive health presents a growing public health concern. With all four serotypes co-circulating in endemic regions and sequential infections being common, it remains unknown whether repeated exposure has any cumulative impact on testicular function or sperm quality, as this has not been investigated in clinical or experimental studies to date. Furthermore, no studies have delineated serotype-specific effects on sperm DNA fragmentation, representing a critical gap in the current literature. From a clinical perspective, incorporating recent dengue infection history into male infertility assessments may provide valuable context, particularly in endemic settings. Post-infection semen analysis, including the assessment of DNA fragmentation indices, may be warranted in selected cases. These considerations are especially relevant given the global rise in dengue incidence and the increasing recognition of male-factor infertility. Notably, the current evidence base remains limited, with a paucity of longitudinal and multi-cohort studies, underscoring the need for cautious interpretation of existing findings. In conclusion, while ZIKV established the paradigm of flavivirus-associated male reproductive involvement, dengue may represent a more widespread – albeit transient – contributor to impaired sperm integrity. The potential for oxidative stress–mediated DNA damage, coupled with the high global disease burden, underscores the need for targeted research. Future studies should focus on serotype-specific pathogenicity, the duration of sperm DNA fragmentation, long-term fertility outcomes, and potential transgenerational effects. Addressing these gaps will be essential for developing evidence-based clinical and public health guidelines.